MedDataX Logo

Evaluation of Antihypertensive Drugs in OSA Patients

NCT ID: NCT01803815

Last Updated: 2014-11-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

369 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-04-30

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective cohort study aimed to assess the phenotypic characteristics of OSA patients and their pattern of antihypertensive drugs consumption. The investigators also aimed to investigate a hypothetical association between ongoing anti-hypertensive regimen and Blood pressure control rates in these patients. Additionally, the investigators were also interested in trying to understand if the control of OSA may be influenced by the use of different classes of anti-hypertensive drugs.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)

NCT01028534

Obstructive Sleep Apnea Hypertension
COMPLETED NA

A Cross-sectional Study of the Occurrence and Effect of Obstructive Sleep Apnea in Subjects With Resistant Hypertension

NCT00843583

Obstructive Sleep Apnea Resistant Hypertension
COMPLETED

Obstructive Sleep Apnea and Endothelial Function in Patients With Resistant Hypertension

NCT01854190

Obstructive Sleep Apnea Secondary Hypertension
COMPLETED

Kynurenine/Tryptophan Ratio in Hypertension Associated to Obstructive Sleep Apnea

NCT04646902

Hypertension Secondary
ACTIVE_NOT_RECRUITING

Antihypertensive Effect of Continuous Positive Airway Pressure in Resistant Hypertensive Patients With Sleep Apnea

NCT00929175

Hypertension
COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension Obstructive Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged above 18 years, that attended a first visit at CHLN Hospital Sleep Unit were enrolled

Exclusion Criteria

* severe psychiatric disease or inability to understand the information required for an informed consent.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidade Nova de Lisboa

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lucilia N Diogo, PharmD, MSc

Role: PRINCIPAL_INVESTIGATOR

Universidade Nova de Lisboa - CEDOC

Paula Pinto, PhD, MD

Role: STUDY_CHAIR

CHLN

Cristina Bárbara, PhD, MD

Role: STUDY_CHAIR

CHLN

Emilia C Monteiro, PhD, MD

Role: STUDY_DIRECTOR

Universidade Nova de Lisboa

Ana L Papoila, PhD

Role: STUDY_DIRECTOR

Universidade Nova de Lisboa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universidade Nova de Lisboa - Faculdade de Ciências Médicas

Lisbon, , Portugal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Portugal

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NOVA - CEDOC/FCT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Efficacy of CPAP Treatment on Blood Pressure of Resistant Hypertension Patients With Obstructive Sleep Apnea Syndrome
NCT01508754 COMPLETED PHASE4
Diurnal Evaluation of OSA Upper Airway Collapsibility and Muscle Responsiveness
NCT06334601 RECRUITING
Masked Hypertension in Patients With Obstructive Sleep Apnoea
NCT03869125 COMPLETED
Association Between Obstructive Sleep Apnea and Bruxism
NCT03810248 COMPLETED
Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension
NCT05595200 RECRUITING
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
NCT05804084 RECRUITING PHASE2
Effect of CPAP on Blood Pressure in Patients With Sleep Apnea and Refractory Hypertension
NCT00863135 COMPLETED NA
Cardiovascular Phenotype Study in Patients With Obstructive Sleep Apnea Syndrome
NCT00764218 UNKNOWN EARLY_PHASE1
New Perspective on Exploring the Post-apneic BP Surge in Patients With OSA
NCT06172998 RECRUITING EARLY_PHASE1
Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients.
NCT01875341 COMPLETED PHASE3
Clinical Characteristics of Patients With Sleep Apnea in Korea
NCT04186078 RECRUITING
Home Nasal Pressure for Sleep Apnea Management in Primary Case
NCT02141165 COMPLETED NA
Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide
NCT02710071 COMPLETED PHASE4
CPAP in SAHS Patients With Hypertension
NCT02398032 COMPLETED PHASE4
Obstructive Sleep Apnea (OSA) in Pulmonary Arterial Hypertension (PAH)
NCT01835080 TERMINATED
Efficiency of Speech Therapy in Resistant Hypertensive Patients With Mild Obstructive Sleep Apnea Syndrome
NCT03753633 UNKNOWN NA
Effect of Continuous Positive Airway Pressure for Treatment of Obstructive Sleep Apnea on Resistant Hypertension
NCT00881985 COMPLETED NA
Obstructive Sleep Apnoea in Patients With Intermittent Claudication
NCT01801592 COMPLETED
Screening of Obstructive Sleep Apnea Syndrome in Patients With Resistant Systemic Arterial Hypertension: Pilot Study
NCT03257488 UNKNOWN NA
Echocardiographic Assessment of Pulmonary Hypertension in Obstructive Sleep Apnea
NCT07184060 NOT_YET_RECRUITING
Continuous Monitoring Nocturnal Beat-to-beat Blood Pressure Fluctuation in OSA With or Without Hypertension
NCT02876471 COMPLETED NA
Normotensive OSA Patients With Nondipper Circadian Blood Pressure Pattern
NCT03987425 COMPLETED NA
Diagnosis of Patients With Low or Intermediate Suspicion of SAHS or With Comorbidity: Standard Laboratory Polysomnography Compared With Three Nights of Home Respiratory Polygraphy.
NCT01820156 COMPLETED NA
Sleep Schedules Modifications in Sleep Apnea Patients Treated by nCPAP
NCT01355419 COMPLETED
Sleep Apnea and Refractory Hypertension: Prevalence and Effect of CPAP Treatment
NCT00459914 COMPLETED PHASE2